Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hart, P. H.
Right arrow Articles by Hamilton, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hart, P. H.
Right arrow Articles by Hamilton, J. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Interleukin-4 stimulates human monocytes to produce tissue-type plasminogen activator

PH Hart, DR Burgess, GF Vitti and JA Hamilton

University of Melbourne, Department of Medicine, Parkville, Victoria, Australia.

Tissue-type plasminogen activator (t-PA) is involved in the lysis of blood clots (fibrinolysis) and is used clinically for this purpose. Endothelial cells are one source of the t-PA present in blood. We report here that interleukin-4 (IL-4) (0.1 to 0.25 U/mL; 1 to 3 x 10(- 11) mol/L), but not interferon-gamma (IFN-gamma), elevates t-PA messenger (m)RNA expression and secretion of t-PA activity by human monocytes, with the maximum response at 2.5 U/mL. Supernatant t-PA activity was detected within three hours of exposure to IL-4 and maximum activity within six hours. Thus, IL-4 may control fibrin deposition at sites of inflammation during cell-mediated immune responses, as well as having a therapeutic role in thrombolysis.

Volume 74, Issue 4, pp. 1222-1225, 09/01/1989
Copyright © 1989 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. N Bittar, N. H Khasati, A. K Deiraniya, and N. Yonan
Interleukin-4 C-590T Polymorphism Has No Role in Coronary Artery Bypass Surgery
Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 214 - 217.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Shimizu, R. N. Mitchell, and P. Libby
Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms
Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 987 - 994.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Brownstein, A. B. Deora, A. T. Jacovina, R. Weintraub, M. Gertler, K. M. F. Khan, D. J. Falcone, and K. A. Hajjar
Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages
Blood, January 1, 2004; 103(1): 317 - 324.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Profita, A. Sala, L. Siena, P. M. Henson, R. C. Murphy, A. Paterno, A. Bonanno, L. Riccobono, A. Mirabella, G. Bonsignore, et al.
Leukotriene B4 Production in Human Mononuclear Phagocytes Is Modulated by Interleukin-4-Induced 15-Lipoxygenase
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 868 - 875.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Chizzolini, R. Rezzonico, C. De Luca, D. Burger, and J.-M. Dayer
Th2 Cell Membrane Factors in Association with IL-4 Enhance Matrix Metalloproteinase-1 (MMP-1) While Decreasing MMP-9 Production by Granulocyte-Macrophage Colony-Stimulating Factor-Differentiated Human Monocytes
J. Immunol., June 1, 2000; 164(11): 5952 - 5960.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Bickerstaff, D. Xia, R. P. Pelletier, and C. G. Orosz
Mechanisms of Graft Acceptance: Evidence That Plasminogen Activator Controls Donor-Reactive Delayed-Type Hypersensitivity Responses in Cardiac Allograft Acceptor Mice
J. Immunol., May 15, 2000; 164(10): 5132 - 5139.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. T. Smiley, S. N. Boyer, M. J. Heeb, J. H. Griffin, and M. J. Grusby
Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity
PNAS, October 14, 1997; 94(21): 11484 - 11489.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Wang, H. J. Chen, K. N. Giedd, A. Schwartz, P. J. Cannon, and L. E. Rabbani
T-Cell Lymphokines, Interleukin-4 and Gamma Interferon, Modulate the Induction of Vascular Smooth Muscle Cell Tissue Plasminogen Activator and Migration by Serum and Platelet-Derived Growth Factor
Circ. Res., December 1, 1995; 77(6): 1095 - 1106.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
K. A. Gossett, T. A. Barbolt, J. B. Cornacoff, D. J. Zelinger, and J. H. Dean
Clinical Pathologic Alterations Associated with Subcutaneous Administration of Recombinant Human Interleukin-4 to Cynomolgus Monkeys
Toxicol Pathol, January 1, 1993; 21(1): 46 - 53.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1989 by American Society of Hematology         Online ISSN: 1528-0020